Sensum Sars Cov-2 EN

Sensum Sars Cov-2

Invention patent No. NC2020/0016204, Colombia (pending)

SENSUM SARS Cov-2 is a portable, low-cost electrochemical sensor for the non-invasive, rapid and accurate quantification and detection of coronavirus-2 in symptomatic and asymptomatic patients.

medicine / pharmaceuticals

minimally invasive, real-time results, adaptable to other pathogens and ultra-sensitive (pre- and asymptomatic patients).

It facilitates the return to productive and social activities through the immediate and accurate identification of carriers of the SARS-CoV-2 virus.
Ultra-sensitive and selective to SARS-CoV-2 (94% sensitivity and up to 96% selectivity).
It does not require amplification of genetic material.

Pontificia Universidad Javeriana de Cali

TRL7